1
|
Le Bagousse-Bernard A, Dussart C, Pin P, Tazarourte K, Fattoum J. Mass COVID-19 vaccination center: Optimizing the vaccination pathway during a 12 month timeframe. Vaccine 2024; 42:126101. [PMID: 39003105 DOI: 10.1016/j.vaccine.2024.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2023] [Revised: 05/01/2024] [Accepted: 07/02/2024] [Indexed: 07/15/2024]
Abstract
BACKGROUND In France, the COVID-19 vaccination campaign started in January 2021. This study reports the one-year experience of a multidisciplinary team from university hospital in operating a vaccination center created in a metropolitan sports arena. MATERIALS AND METHODS Some of the data derive from an online appointment scheduling software. Daily traceability sheets were utilized as a formalized method to gather data on non-conformities, adverse events, and to estimate the duration of the vaccination pathway. The professional satisfaction assessment was carried out via an anonymous online questionnaire. The collected data were examined with descriptive statistics. RESULTS We propose strengths of our organization to obtain efficient and safe vaccination pathway. In one year, 572,491 immunization shots were administered. The operational team size increased from 31 (500 vaccinations per day) to 71 (3000 vaccinations per day). In March 2021, the average duration to vaccination (excluding post-vaccination monitoring) was 12 [5-37] minutes for patients without medical consultation vs 16 [5-45] minutes for patients with medical consultation. 0.11 % non-conformities on vaccines got notified not allowing them to be used for vaccination. One error regarding the volume administered got reported. Among the professionals working in the vaccination center, 97 % were satisfied with the organization and 88 % with the quality of the information received from team leader or team project. Main difficulties encountered were managing the leftover doses at night and communicating with patients. CONCLUSIONS Overall, the ability to vaccinate a population efficiently and safely on a large scale during a pandemic is based on the engagement of skilled multidisciplinary teams and securing the vaccination pathway.
Collapse
Affiliation(s)
| | | | - Philippe Pin
- Resources and Purchasing Department, Hospices Civils de Lyon, Lyon, France
| | - Karim Tazarourte
- Emergency Medical Service, Hospices Civils de Lyon, Lyon, France
| | - Jihane Fattoum
- Emergency Medical Service, Hospices Civils de Lyon, Lyon, France
| |
Collapse
|
2
|
Green-McKenzie J, Field-Flowers C, Peairs K, Barnes K, Shofer F, Kuter BJ. Best Practices for Implementation of an Employee Health COVID-19 Vaccine Clinic-A Model for Future Pandemic Preparedness. J Occup Environ Med 2023; 65:621-626. [PMID: 37043395 PMCID: PMC10417232 DOI: 10.1097/jom.0000000000002860] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/13/2023]
Abstract
OBJECTIVES The aims of the study are to determine best practices from two large-scale, academic medical centers' employee coronavirus 2019 (COVID-19) vaccination clinics and to apply them to create scalable modules for rapid administration of 10,000 vaccinations. METHODS The weekly number of COVID-19 vaccine doses administered was captured. Processes were compared to determine best practices, which informed the scalable financial model. RESULTS Within the first 3 months, more than 60,000 COVID-19 vaccine doses were administered, and 70% of employees were fully vaccinated in 4 months with more than 95% by the vaccine mandate deadline. The estimated cost of delivering one dose was $29.95 ($299,505/10,000) compared with $35-$39 per dose when delivered by an on-site retail pharmacy. CONCLUSIONS Successful, safe, and rapid delivery of more than 60,000 COVID-19 vaccine doses in 3 months is practical and scalable. Learnings go beyond COVID-19 and can be applied to future outbreaks/pandemics.
Collapse
|
3
|
Tregnaghi P, Ospina-Henao S, Maldonado Oliva C, Bocanegra CL, Toledo C, Aldaz C, Pérez G, Díaz Ortega JL, Castelli JM, Aguilar L, Oliva L, Jiménez Quinteros M, Enriquez Navas M, Arroba R. Innovation and immunization program management: traceability and quality in Latin America and the Caribbean, laying the groundwork for a regional action plan. Expert Rev Vaccines 2022; 21:1023-1028. [PMID: 35549597 DOI: 10.1080/14760584.2022.2077195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
INTRODUCTION The Latin American Society of Pediatric Infectious Diseases (SLIPE by its Spanish acronyms) is working to understand the current situation, gaps, and opportunities for traceability of the quality vaccination process in Latin America and the Caribbean. AREAS COVERED On September 24th and 25th, a Latin American forum of experts in immunization programs was held through the Zoom platform; the topics discussed included: computerized systems for recording immunizations, vaccination programs traceability, challenges, and information systems for the integrated management of vaccination. EXPERT OPINION Latin American countries have transitioned from having a nominal registration system to a nominal tracking system, with many of them not migrating their platforms to new technologies; therefore, the low-quality data, fragmented databases, and slow information traffic present a challenge that must be taken on.
Collapse
Affiliation(s)
- Pablo Tregnaghi
- Academic Committee of Computerized Medicine, Latin American Society of Pediatric Infectology, Buenos Aires, Argentina
| | - Sebastián Ospina-Henao
- Instituto de Investigación en Ciencias Médicas (IICIMED), Faculty of Medicine, Universidad de Ciencias Médicas (UCIMED), San José, Costa Rica
| | | | | | - Christian Toledo
- Public Health Surveillance, Ministry of Health, Managua, Nicaragua
| | - Cristina Aldaz
- National Vaccination Plan, Ministry of Health, Quito, Ecuador
| | - Graciela Pérez
- Department of Immunizations, Ministry of Health, Montevideo, Uruguay
| | | | | | - Lourdes Aguilar
- Health Statistics Area, Ministry of Health, Tegucigalpa, Honduras
| | - Luis Oliva
- National Authority for Government Innovation, Ministry of Health, Panama City, Panama
| | | | | | - Roberto Arroba
- Department of Immunizations, Ministry of Health, San José, Costa Rica
| |
Collapse
|
4
|
Ribera-Cano A, Dupont M, Houzé-Cerfon CH, Houzé-Cerfon V, Hart A, Hertelendy AJ, Ciottone G, Bounes V. Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France. Vaccine 2021; 39:7441-7445. [PMID: 34782160 PMCID: PMC8563340 DOI: 10.1016/j.vaccine.2021.10.080] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Revised: 10/01/2021] [Accepted: 10/28/2021] [Indexed: 10/26/2022]
Abstract
AIM OF THE STUDY In the context of the worldwide vaccination campaign against COVID-19, France has been deploying multiple sites for mass vaccination. This study aimed to assess the perceived usefulness of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination among both the patient and healthcare providers perspectives. METHODS This was a descriptive cross-sectional study conducted in Toulouse over two days. UMDEO is a fully comprehensive, versatile solution that was deployed as a 5-row vaccination unit. A written questionnaire was distributed from March 6th-7th, 2021 among all patients presenting for vaccination at the mobile center, as well as the team participating in the vaccination campaign. RESULTS Among the vaccinated patients (n = 1659), 1409 participants (84.9%) filled out the survey, as well as 68 out of 85 (80%) within the UMDEO team. The maximum patient rate was 98 people per hour. The majority of participants and caregivers (1307 [93.2%] and 67 [98.5%] respectively) agreed that the mobile unit increased access to vaccination. A total of 91.3% patients (n = 1281) and 95.6% caregivers (n = 65) believed that it would speed up the overall vaccination campaign. CONCLUSION The majority of the vaccinated population and of the team participating in the survey were satisfied with the usefulness of UMDEO as a vaccination center. Toulouse is currently the only city to have used such a structure for vaccination, but it could be used as a basis for planning other mobile units to increase vaccination access.
Collapse
Affiliation(s)
- Anna Ribera-Cano
- SAMU 31, Disaster Medicine Unit, Toulouse University Hospital, 31059 Toulouse, France
| | - Maud Dupont
- Emergency Department, Toulouse UniversiCty Hospital, 31059 Toulouse, France
| | - Charles-Henri Houzé-Cerfon
- Toulouse Institute of Simulation Healthcare (Institut Toulousain de Simulation en Santé, ItSimS), University Hospital Toulouse, Toulouse, France; Emergency Department, Toulouse UniversiCty Hospital, 31059 Toulouse, France
| | | | - Alexander Hart
- Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, USA
| | - Attila J Hertelendy
- Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, USA
| | - Gregory Ciottone
- Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, USA
| | - Vincent Bounes
- SAMU 31, Disaster Medicine Unit, Toulouse University Hospital, 31059 Toulouse, France
| |
Collapse
|
5
|
Abstract
Mass vaccination campaigns have been used effectively to limit the impact of communicable disease on public health. However, the scale of the coronavirus disease (COVID-19) vaccination campaign is unprecedented. Mass vaccination sites consolidate resources and experience into a single entity and are essential to achieving community ("herd") immunity rapidly, efficiently, and equitably. Health care systems, local and regional public health entities, emergency medical services, and private organizations can rapidly come together to solve problems and achieve success. As medical directors at several mass vaccination sites across the United States, we describe key mass vaccination site concepts, including site selection, operational models, patient flow, inventory management, staffing, technology, reporting, medical oversight, communication, and equity. Lessons learned from experience operating a diverse group of mass vaccination sites will help inform not only sites operating during the current pandemic, but also may serve as a blueprint for future outbreaks of highly infectious communicable disease.
Collapse
|
6
|
Jasani GN, Alfalasi R, Cavaliere GA, Lawner BJ, Liang SY. Terrorist Attacks Against Vaccinators: A Review. Health Secur 2021; 19:541-545. [PMID: 34529507 DOI: 10.1089/hs.2021.0078] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Vaccinators fulfill an important role in a nation's public health by reducing the burden of disease on the population. Understanding patterns of attack employed against vaccinators is important to determine how to protect them. We conducted a search of the Global Terrorism Database for terrorist attacks against vaccinators that occurred between the years 1970 and 2018. Using the search terms "hospital," "healthcare," "clinic," "doctor," "nurses," "vaccinators," and "vaccinations," 2,322 healthcare-related entries were identified. We then manually searched the dataset for incidents related to attacks on vaccinators, which resulted in the identification of 133 attacks against vaccinators. The majority (128 out of 133) of attacks occurred during or after 2010. Every attack except one has occurred in the Middle East, South Asia, or sub-Saharan Africa. Pakistan has seen the most attacks against vaccinators, with 112 incidents recorded. Vaccinators continue to be vulnerable to terrorist attacks. Protection of healthcare personnel during mass vaccination efforts is critical so that they can continue their lifesaving mission.
Collapse
Affiliation(s)
- Gregory N Jasani
- Gregory N. Jasani, MD, Reem Alfalasi, MBChB, and Garrett A. Cavaliere, DO, NRP, are Residents, Department of Emergency Medicine, University of Maryland Medical Center, Baltimore, MD. Benjamin J. Lawner, DO, EMT-P, is an Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine, and Medical Director, Maryland ExpressCare Critical Care Transport Program; both in Baltimore, MD. Stephen Y. Liang, MD, MPHS, is Associate Professor, Division of Infectious Diseases and Division of Emergency Medicine, Washington University School of Medicine, St. Louis, MO
| | - Reem Alfalasi
- Gregory N. Jasani, MD, Reem Alfalasi, MBChB, and Garrett A. Cavaliere, DO, NRP, are Residents, Department of Emergency Medicine, University of Maryland Medical Center, Baltimore, MD. Benjamin J. Lawner, DO, EMT-P, is an Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine, and Medical Director, Maryland ExpressCare Critical Care Transport Program; both in Baltimore, MD. Stephen Y. Liang, MD, MPHS, is Associate Professor, Division of Infectious Diseases and Division of Emergency Medicine, Washington University School of Medicine, St. Louis, MO
| | - Garrett A Cavaliere
- Gregory N. Jasani, MD, Reem Alfalasi, MBChB, and Garrett A. Cavaliere, DO, NRP, are Residents, Department of Emergency Medicine, University of Maryland Medical Center, Baltimore, MD. Benjamin J. Lawner, DO, EMT-P, is an Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine, and Medical Director, Maryland ExpressCare Critical Care Transport Program; both in Baltimore, MD. Stephen Y. Liang, MD, MPHS, is Associate Professor, Division of Infectious Diseases and Division of Emergency Medicine, Washington University School of Medicine, St. Louis, MO
| | - Benjamin J Lawner
- Gregory N. Jasani, MD, Reem Alfalasi, MBChB, and Garrett A. Cavaliere, DO, NRP, are Residents, Department of Emergency Medicine, University of Maryland Medical Center, Baltimore, MD. Benjamin J. Lawner, DO, EMT-P, is an Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine, and Medical Director, Maryland ExpressCare Critical Care Transport Program; both in Baltimore, MD. Stephen Y. Liang, MD, MPHS, is Associate Professor, Division of Infectious Diseases and Division of Emergency Medicine, Washington University School of Medicine, St. Louis, MO
| | - Stephen Y Liang
- Gregory N. Jasani, MD, Reem Alfalasi, MBChB, and Garrett A. Cavaliere, DO, NRP, are Residents, Department of Emergency Medicine, University of Maryland Medical Center, Baltimore, MD. Benjamin J. Lawner, DO, EMT-P, is an Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine, and Medical Director, Maryland ExpressCare Critical Care Transport Program; both in Baltimore, MD. Stephen Y. Liang, MD, MPHS, is Associate Professor, Division of Infectious Diseases and Division of Emergency Medicine, Washington University School of Medicine, St. Louis, MO
| |
Collapse
|